OncoSec Medical Incorporated
ONCSQ · OTC
7/31/2022 | 7/31/2021 | 7/31/2020 | 7/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | -1,105.25% | -593.32% | -477.29% | -1,843.13% |
| EV / EBITDA | 0.09 | 0.68 | 0.13 | 0.78 |
| Quality | ||||
| ROIC | -195.00% | -91.14% | -196.04% | -121.68% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.94 | 0.93 | 0.78 | 0.96 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 23.97% | -28.51% | -14.24% | -24.59% |
| Safety | ||||
| Net Debt / EBITDA | 0.17 | 0.83 | 0.30 | 0.83 |
| Interest Coverage | -1,768.80 | -3,051.02 | -8,488.28 | -7,993.87 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -3,564.78 |